Table 3. Association of BRCA1 and ERCC1 and the effect of chemotherapy in primary nasopharyngeal carcinoma and cervical lymph node.
Expression | Response | ||||||
---|---|---|---|---|---|---|---|
In primary | N | CR+PR | SD+PD | RR (%) | X2 | P1 | |
BRCA1 | |||||||
+ | 129 | 72 | 57 | 55.8 | 6.224 | 0.013 | |
- | 72 | 53 | 19 | 73.6 | |||
ERCC1 | |||||||
+ | 136 | 77 | 59 | 56.6 | 7.795 | 0.005 | |
- | 65 | 50 | 15 | 76.9 | |||
BRCA1 | ERCC1 | ||||||
+ | + | 103 | 54 | 49 | 52.4 | 12.840 | 0.005 |
- | - | 39 | 32 | 7 | 82.1 | ||
+ | - | 26 | 19 | 7 | 73.1 | ||
- | + | 33 | 23 | 10 | 69.6 | ||
In cervical lymph node | |||||||
BRCA1 | |||||||
+ | 129 | 86 | 43 | 66.6 | 4.387 | 0.036 | |
- | 72 | 58 | 14 | 80.5 | |||
ERCC1 | |||||||
+ | 136 | 89 | 47 | 65.4 | 5.496 | 0.019 | |
- | 65 | 53 | 12 | 81.5 | |||
BRCA1 | ERCC1 | ||||||
+ | + | 103 | 62 | 41 | 60.1 | 8.831 | 0.032 |
- | - | 39 | 33 | 6 | 84.6 | ||
+ | - | 26 | 20 | 6 | 76.9 | ||
- | + | 33 | 24 | 9 | 72.7 |
1Statistical analysis was estimated by χ2 test, and P < 0.05 was considered statistically significant; CR, complete response; PR, partial response; SD, stable disease; PD, progressive disease, RR, response rate.